Skip to main content
SpringerLink
Log in

Review: The Role of Hyperthermia in Treating Pancreatic Tumors

  • Review Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

There is only marginal improvement in outcome of treating pancreatic cancer in the last two decades. Time to open up and have a fresh look at complementary adjuvant treatment options. Hyperthermia may be one such option. Hyperthermic intraperitoneal chemotherapy (HIPEC) predominantly as a intrasurgical procedure has already proved its justification. Non-invasive loco regional hyperthermia as complement to either chemo or radiation has not yet reached a comparable status of evidence. However the potential to eventually grow into such evidence is already clearly observable. This review presents the various methodologies available for hyperthermia, covers the initial clinical data that has been published and gives an outlook to what can be expected in the next 2–3 years to come. Hyperthermia has the potential to significantly prolong life expectancies and this while maintaining a satisfying quality of life!

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Burris HA 3rd, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6):2403–2413

    CAS  PubMed  Google Scholar 

  2. Riess H, Helm A, Niedergethmann M et al (2005) A randomised, prospective, multicenter, phase III trial of gemcitabine, 5-fluorouracil (5-FU), folinic acid vs. gemcitabine alone in patients with advanced pancreatic cancer. Proc. ASCO; Abstr No: 4009

  3. Conroy T, Desseigne F, Ychou M et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364(19):1817–1825

    Article  CAS  PubMed  Google Scholar 

  4. Bakshandeh-Bath A, Stoltz AS, Homann N, Wagner T, Stölting S, Peters SO (2009) Preclinical and clinical aspects of carboplatin and gemcitabine combined with whole-body hyperthermia for pancreatic adenocarcinoma. Anticancer Res 29(8):3069–3077

    CAS  PubMed  Google Scholar 

  5. Yamada S, Takai Y, Nemoto K, Ogawa Y, Kakuto Y, Hoshi A, Sakamoto K, Kimura Y, Kobari M (1992) Intraoperative radiation therapy combined with hyperthermia against pancreatic carcinoma. Int J Oncol 1(7):795–798

    CAS  PubMed  Google Scholar 

  6. Kouloulias VE, Kouvaris JR, Nikita KS, Golematis BC, Uzunoglu NK, Mystakidou K, Papavasiliou C, Vlahos L (2002) Intraoperative hyperthermia in conjunction with multi-schedule chemotherapy (pre-, intra- and post-operative), by-pass surgery, and post-operative radiotherapy for the management of unresectable pancreatic adenocarcinoma. Int J Hyperth 18(3):233–252

    Article  CAS  Google Scholar 

  7. Nakagawa A, Kamiyama Y, Matsui Y, Okuno M, Imamura A, Tu W, Nakagawa M, Kanemaki T, Takai S, Uetsuji S, Noro C, Kubo N, Nakase Y (1996) Selective thermocoagulation of unresectable malignant tumors using radiofrequency [Article in Japanese]. RiGan To Kagaku Ryoho 23(12):1651–1653

    CAS  Google Scholar 

  8. Sugarbaker PH, Stuart OA, Bijelic L (2011) Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report of early data. Int J Surg Oncol 2011:185092. doi:10.1155/2011/185092

  9. Esquivel J et al (2006) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol. doi:10.1245/s10434-006-9185-7

    Google Scholar 

  10. Mi D-H, Li Z, Yang K-H, Cao N, Lethaby A, Tian J-H, Santesso N, Ma B, Chen Y-L, Liu Y-L (2013) Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials. Int J Hyperth 29(2):156–167

    Article  CAS  Google Scholar 

  11. Xiaoping L, Leizhen Z (2013) Advances of high intensity focused ultrasound (HIFU) for pancreatic cancer. Int J Hyperth 29(7):678–682

    Article  Google Scholar 

  12. Wang K, Chen L, Meng Z, Lin J, Zhou Z, Wang P, Chen Z (2012) High intensity focused ultrasound treatment for patients with advanced pancreatic cancer: a preliminary dosimetric analysis. Int J Hyperth 28(7):645–652

    Article  Google Scholar 

  13. Zhao H, Yang G, Wang D, Yu X, Zhang Y, Zhu J, Ji Y, Zhong B, Zhao W, Yang Z, Aziz F (2010) Concurrent gemticatbine and high-intensity fucused ultrasound therapy in patients with locally advanced pancreatic cancer. Anticancer Drugs 21(4):447–452

    Article  CAS  PubMed  Google Scholar 

  14. Van der Zee J, Vujaskovic Z, Kondo M, Sugarhara T (2008) Part I. Clinical hyperthermia. The Kadota Fund International Forum 2004 – clinical group consensus. Int J Hyperth 24(2):111–122

    Article  Google Scholar 

  15. Kandel S, Kloeters C, Meyer H, Hein P, Hilbig A, Rogalla P (2009) Whole-organ perfusion of the pancreas using dynamic volume CT in patients with primary pancreas carcinoma: acquisition technique, post-processing and initial results. Eur Radiol 19(11):2641–2646

    Article  PubMed  Google Scholar 

  16. Fatehi D, van der Zee J, Notenboom A, van Rhoon GC (2007) Comparison of intratumor and intraluminal temperatures during locoregional deep hyperthermia of pelvic tumors. Strahlenther Onkol 183:479–486

    Article  PubMed  Google Scholar 

  17. Hahn GM, Braun J, Har-Kedar I (1975) Thermochemotherapy: synergism between hyperthermia 42–43 degrees) and Adriamycin (of bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci U S A 72:937–940

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Raoof M, Cisneros BT, Corr SJ, Palalon F, Curley SA, Koshkina NV (2013) Tumor selective hyperthermia induced by short-wave capacitively-coupled RF electric-fields. PLoS One 4:8(7)

    Google Scholar 

  19. Adachi S, Kokura S, Okayama T, Ishikawa T, Takagi T, Handa O, Naito Y, Yoshikawa T (2009) Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines. Int J Hyperth 25(3):210–219

    Article  CAS  Google Scholar 

  20. Bull JM, Scott GL, Strebel FR, Nagle VL, Oliver D, Redwine M, Rowe RW, Ahn CW, Koch SM (2008) Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol. Int J Hyperth 24(8):649–662

    Article  CAS  Google Scholar 

  21. Apetoh L, Tesniere A, Ghiringhelli F, Kroemer G, Zitvogel L (2008) Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Res 68(11):4026–4030

    Article  CAS  PubMed  Google Scholar 

  22. Horsman MR, Overgaard J (2007) Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol 19:418–426

    Article  CAS  Google Scholar 

  23. Rubner Y, Wunderlich R, Rühle PF, Kulzer L, Werthmöller N, Frey B, Weiss EM, Keilholz L, Fietkau R, Gaip US (2012) How does ionizing irradiation contribute to the induction of anti-tumor immunity? Front Oncol 2:75

    Article  PubMed Central  PubMed  Google Scholar 

  24. Hager ED, Migeod F, Koomagi R, Schrittwieser G, Krautgartner I (2006) Multimodal complementary therapy for advanced pancreas carcinoma; translation of publication of Deutsche. Zeitschrift für Onkologie 38:100–107

    Article  Google Scholar 

  25. Mueller-Huebenthal B (2010) Hyperthermia and gemcitabine for the treatment of advanced inoperable pancreatic cancer: a retrospective analysis of 25 cases. Presentation at the 6th binneal conference of Indian Association of Hyperthermia Oncology IAHOM; Jan 2010 Bangalore. (Updated data to be published 2014)

  26. Sridhar PS (2012) Pain reduction in hyperthermia: 10 cases. Presentation at the 7th biennal conference of IAHOM, Febr. 2012 Indore

  27. Lee GY, Qian WP, Wang L, Wang YA, Staley CA, Satpathy M, Nie S, Mao H, Yang L (2013) Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer. ACS Nano 7(3):2078–2089

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Kim DH, Guo Y, Zhang Z, Procissi D, Nicolai J, Omary RA, Larson AC (2013) Temperature-sensitive magnetic drug carriers for concurrent gemcitabine chemohyperthermia. Adv Healthc Mater 3(5):714–24. doi:10.1002/adhm.201300209

  29. McDaniel JR, Dewhirst MW, Chilkoti A (2013) Actively targeting solid tumours with thermoresponsive drug delivery systems that respond to mild hyperthermia. Int J Hyperth 29(6):501–510

    Article  CAS  Google Scholar 

  30. Zhang LP, Nie Q, Kang JB, Wang B, Cai CL, Li JG, Qi WJ (2008) Efficacy of whole body gamma-knife radiotherapy combined with thermochemotherapy on locally advanced pancreatic cancer. Ai Zheng 27(11):1204–1207, Article in Chinese

    PubMed  Google Scholar 

  31. Maluta S, Schaffer M, Pioli F, Dall’oglio S, Pasetto S, Schaffer PM, Weber B, Giri MG (2011) Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer: an open-label comparative cohort trial. Strahlenther Onkol 187(10):619–625

    Article  PubMed  Google Scholar 

  32. Ishikawa T, Kokura S, Sakamoto N et al (2012) Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer. Int J Hyperth 28(7):597–604

    Article  CAS  Google Scholar 

  33. Tschoep-Lechner KE, Milani V, Berger F, Dieterle N, Abdel-Rahman S, Salat C, Issels RD (2013) Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer. Int J Hyperth 29(1):8–16

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research & Development Celsius42+, Mannheim, Germany

    Martin Roesch

  2. Oncology, Paracelsus Klinik, Zurich-Richterswil, Switzerland

    Boris Mueller-Huebenthal

Authors
  1. Martin Roesch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Boris Mueller-Huebenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Roesch.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Roesch, M., Mueller-Huebenthal, B. Review: The Role of Hyperthermia in Treating Pancreatic Tumors. Indian J Surg Oncol 6, 75–81 (2015). https://doi.org/10.1007/s13193-014-0316-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-014-0316-5

Keywords

Search

Navigation